CVRx, Inc. Release: Millions of Patients May Find Hope in a New Implantable Device Designed to Lower High Blood Pressure in Drug Resistant Hypertension Patients

MINNEAPOLIS--(BUSINESS WIRE)--May is Hypertension Awareness Month, and a new device in high blood pressure clinical trials is showing promise for treating U.S. hypertension (high blood pressure) patients whose condition is not controlled by drugs. Rheos® Hypertension (HT) Therapy is an implantable device designed to lower high blood pressure - the number one risk factor for stroke, heart and kidney disease.